Search Results - "Sywak, Mark"

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer by Xing, Mingzhao, Alzahrani, Ali S, Carson, Kathryn A, Shong, Young Kee, Kim, Tae Yong, Viola, David, Elisei, Rossella, Bendlová, Bela, Yip, Linwah, Mian, Caterina, Vianello, Federica, Tuttle, R Michael, Robenshtok, Eyal, Fagin, James A, Puxeddu, Efisio, Fugazzola, Laura, Czarniecka, Agnieszka, Jarzab, Barbara, O'Neill, Christine J, Sywak, Mark S, Lam, Alfred K, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, Nakayama, Hirotaka, Clifton-Bligh, Roderick, Tallini, Giovanni, Holt, Elizabeth H, Sýkorová, Vlasta

“…To investigate the prognostic value of BRAF V600E mutation for the recurrence of papillary thyroid cancer (PTC). This was a retrospective multicenter study of…”
Get full text

Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer by Shen, Xiaopei, Zhu, Guangwu, Liu, Rengyun, Viola, David, Elisei, Rossella, Puxeddu, Efisio, Fugazzola, Laura, Colombo, Carla, Jarzab, Barbara, Czarniecka, Agnieszka, Lam, Alfred K, Mian, Caterina, Vianello, Federica, Yip, Linwah, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, O'Neill, Christine J, Sywak, Mark S, Clifton-Bligh, Roderick, Bendlova, Bela, Sýkorová, Vlasta, Xing, Mingzhao

“…Purpose For the past 65 years, patient age at diagnosis has been widely used as a major mortality risk factor in the risk stratification of papillary thyroid…”
Get full text

Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy by Kesby, Nicholas L., Papachristos, Alexander J., Gild, Matti, Aniss, Ahmad, Sywak, Mark S., Clifton-Bligh, Roderick, Sidhu, Stan B., Glover, Anthony R.

“…Background Medullary thyroid carcinoma (MTC) can be targeted with tyrosine kinase inhibitors (TKIs). We aimed to report the outcomes of surgically managed MTC…”
Get full text

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer by Xing, Mingzhao, Alzahrani, Ali S, Carson, Kathryn A, Viola, David, Elisei, Rossella, Bendlova, Bela, Yip, Linwah, Mian, Caterina, Vianello, Federica, Tuttle, R. Michael, Robenshtok, Eyal, Fagin, James A, Puxeddu, Efisio, Fugazzola, Laura, Czarniecka, Agnieszka, Jarzab, Barbara, O’Neill, Christine J, Sywak, Mark S, Lam, Alfred K, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, Nakayama, Hirotaka, Tufano, Ralph P, Pai, Sara I, Zeiger, Martha A, Westra, William H, Clark, Douglas P, Clifton-Bligh, Roderick, Sidransky, David, Ladenson, Paul W, Sykorova, Vlasta

“…IMPORTANCE BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its role in PTC-related patient mortality has not been established…”
Get full text

Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance by Lin, Jia F., Jonker, Pascal K.C., Cunich, Michelle, Sidhu, Stanley B., Delbridge, Leigh W., Glover, Anthony R., Learoyd, Diana L., Aniss, Ahmad, Kruijff, Schelto, Sywak, Mark S.

“…Papillary thyroid microcarcinoma is a subtype of thyroid cancer that may be managed with active surveillance rather than immediate surgery. Active surveillance…”
Get full text

BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer by Tao, Yubing, Wang, Fei, Shen, Xiaopei, Zhu, Guangwu, Liu, Rengyun, Viola, David, Elisei, Rossella, Puxeddu, Efisio, Fugazzola, Laura, Colombo, Carla, Jarzab, Barbara, Czarniecka, Agnieszka, Lam, Alfred K, Mian, Caterina, Vianello, Federica, Yip, Linwah, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, O'Neill, Christine J, Sywak, Mark S, Clifton-Bligh, Roderick, Bendlova, Bela, Sýkorová, Vlasta, Zhao, Shihua, Wang, Yangang, Xing, Mingzhao

“…How lymph node metastasis (LNM)-associated mortality risk is affected by BRAF V600E in papillary thyroid cancer (PTC) remains undefined. To study whether BRAF…”
Get full text

The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer by Wang, Fei, Yu, Xiaolong, Shen, Xiaopei, Zhu, Guangwu, Huang, Yueye, Liu, Rengyun, Viola, David, Elisei, Rossella, Puxeddu, Efisio, Fugazzola, Laura, Colombo, Carla, Jarzab, Barbara, Czarniecka, Agnieszka, Lam, Alfred K, Mian, Caterina, Vianello, Federica, Yip, Linwah, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, O’Neill, Christine J, Sywak, Mark S, Clifton-Bligh, Roderick, Bendlova, Bela, Sýkorová, Vlasta, Wang, Yangang, Liu, Shiguo, Zhao, Jiajun, Zhao, Shihua, Xing, Mingzhao

“…Abstract Context Multifocality is often treated as a risk factor for papillary thyroid cancer (PTC), prompting aggressive treatments, but its prognostic value…”
Get full text

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis by Fuchs, Talia L., Nassour, Anthony J., Glover, Anthony, Sywak, Mark S., Sidhu, Stan B., Delbridge, Leigh W., Clifton-Bligh, Roderick J., Gild, Matti L., Tsang, Venessa, Robinson, Bruce G., Clarkson, Adele, Sheen, Amy, Sioson, Loretta, Chou, Angela, Gill, Anthony J.

“…We investigated the prognostic value of a range of histologic parameters in medullary thyroid carcinoma (MTC) to design a grading system to predict overall…”
Get full text

MicroRNA‐222 and MicroRNA‐146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer by Lee, James C., Zhao, Jing Ting, Clifton‐Bligh, Roderick J., Gill, Anthony, Gundara, Justin S., Ip, Julian C., Glover, Anthony, Sywak, Mark S., Delbridge, Leigh W., Robinson, Bruce G., Sidhu, Stanley B.

“…BACKGROUND Papillary thyroid cancer (PTC) persistence or recurrence and the need for long‐term surveillance can cause significant inconvenience and morbidity…”
Get full text

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants by Shi, Xiaoguang, Liu, Rengyun, Basolo, Fulvio, Giannini, Riccardo, Shen, Xiaopei, Teng, Di, Guan, Haixia, Shan, Zhongyan, Teng, Weiping, Musholt, Thomas J, Al-Kuraya, Khawla, Fugazzola, Laura, Colombo, Carla, Kebebew, Electron, Jarzab, Barbara, Czarniecka, Agnieszka, Bendlova, Bela, Sykorova, Vlasta, Sobrinho-Simões, Manuel, Soares, Paula, Shong, Young Kee, Kim, Tae Yong, Cheng, Sonia, Asa, Sylvia L, Viola, David, Elisei, Rossella, Yip, Linwah, Mian, Caterina, Vianello, Federica, Wang, Yangang, Zhao, Shihua, Oler, Gisele, Cerutti, Janete M, Puxeddu, Efisio, Qu, Shen, Wei, Qing, Xu, Huixiong, O'Neill, Christine J, Sywak, Mark S, Clifton-Bligh, Roderick, Lam, Alfred K, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, Yu, Hongyu, Tallini, Giovanni, Holt, Elizabeth H, Vasko, Vasily, Xing, Mingzhao

“…Context: Individualized management, incorporating papillary thyroid cancer (PTC) variant-specific risk, is conceivably a useful treatment strategy for PTC,…”
Get full text

ASO Visual Abstract: Outcomes of Advanced MTC in the Era of Targeted Therapy by Kesby, Nicholas L., Papachristos, Alexander J., Gild, Matti, Aniss, Ahmad, Sywak, Mark S., Clifton-Bligh, Roderick, Sidhu, Stan B., Glover, Anthony R.

Get full text

BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma by Kim, Kyeong J., Kim, Sin G., Tan, Jie, Shen, Xiaopei, Viola, David, Elisei, Rossella, Puxeddu, Efisio, Fugazzola, Laura, Colombo, Carla, Jarzab, Barbara, Czarniecka, Agnieszka, Lam, Alfred K., Mian, Caterina, Vianello, Federica, Yip, Linwah, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, O'Neill, Christine J., Sywak, Mark S., Clifton-Bligh, Roderick, Bendlova, Bela, Sýkorová, Vlasta, Xing, Mingzhao

“…Conservative active surveillance has been proposed for low-risk papillary thyroid microcarcinoma (PTMC), defined as ≤1.0 cm and lacking clinical aggressive…”
Get full text

Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease by van der Plas, Willemijn, Kruijff, Schelto, Sidhu, Stan B., Delbridge, Leigh W., Sywak, Mark S., Engelsman, Anton F.

“…The landscape of patients with end-stage renal disease is changing with the increasing availability of kidney transplantation. In the near future, a less…”
Get full text

Letter to the Editor: Reoperation for Bleeding After Thyroid and Parathyroid Surgery: Incidence, Risk Factors, Prevention, and Management by Di Marco, Aimee N., Glover, Anthony, Sywak, Mark S., Sidhu, Stan B.

Get full text

BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer by Wang, Fei, Zhao, Shihua, Shen, Xiaopei, Zhu, Guangwu, Liu, Rengyun, Viola, David, Elisei, Rossella, Puxeddu, Efisio, Fugazzola, Laura, Colombo, Carla, Jarzab, Barbara, Czarniecka, Agnieszka, Lam, Alfred K, Mian, Caterina, Vianello, Federica, Yip, Linwah, Riesco-Eizaguirre, Garcilaso, Santisteban, Pilar, O'Neill, Christine J, Sywak, Mark S, Clifton-Bligh, Roderick, Bendlova, Bela, Sýkorová, Vlasta, Wang, Yangang, Xing, Mingzhao

“…Purpose To test whether the prognostic risk of male sex in papillary thyroid cancer (PTC) is determined by BRAF V600E and can thus be stratified by BRAF…”
Get full text

miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer by HWA SOON, Patsy Siok, TACON, Lyndal J, SIDHU, Stan B, GILL, Anthony J, BAMBACH, Christopher P, SYWAK, Mark S, CAMPBELL, Peter R, YEH, Michael W, WONG, Steven G, CLIFTON-BLIGH, Roderick J, ROBINSON, Bruce G

“…Purpose: Adrenocortical adenomas are common, whereas adrenocortical carcinomas are rare. Discriminating between benign and malignant adrenocortical tumors…”
Get full text

Bi-national Review of Phaeochromocytoma Care: Is ICU Admission Always Necessary? by Papachristos, Alexander J., Cherry, Tiffany J., Nyandoro, Munyaradzi G., Lisewski, Dean, Stevenson, Sarah-Jayne, Mercer, Philippa, Subramaniam, Suren, Sidhu, Stan B., Sywak, Mark S., Blefari, Nicholas D. A., O’Neill, Christine J., Gundara, Justin S., Miller, Julie A.

“…Background Post-operative management after phaeochromocytoma resection includes monitoring of blood pressure and blood sugar, and vigilance for haemorrhage…”
Get full text

Primary Hyperparathyroidism by diMarco, Aimee N, Sywak, Mark S, Sidhu, Stan B, Choy, Kay W, Insogna, Karl L

“…To the Editor: In his article, Insogna (Sept. 13 issue) 1 notes that “surgical treatment of hyperparathyroidism should incorporate intraoperative PTH…”
Get full text

An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer by Nixon, Iain J, Wang, Laura Y, Migliacci, Jocelyn C, Eskander, Antoine, Campbell, Michael J, Aniss, Ahmad, Morris, Lilah, Vaisman, Fernanda, Corbo, Rossana, Momesso, Denise, Vaisman, Mario, Carvalho, Andre, Learoyd, Diana, Leslie, William D, Nason, Richard W, Kuk, Deborah, Wreesmann, Volkert, Morris, Luc, Palmer, Frank L, Ganly, Ian, Patel, Snehal G, Singh, Bhuvanesh, Tuttle, R Michael, Shaha, Ashok R, Gönen, Mithat, Pathak, K Alok, Shen, Wen T, Sywak, Mark, Kowalski, Luis, Freeman, Jeremy, Perrier, Nancy, Shah, Jatin P

“…Age is a critical factor in outcome for patients with well-differentiated thyroid cancer. Currently, age 45 years is used as a cutoff in staging, although…”
Get more information

Patience is key for the surgeon in the management of a large haemorrhagic phaeochromocytoma with cardiomyopathy by Pasch, James A., Serrao‐Brown, Hazel, Nguyen, Daniel, Samra, Jaswinder S., Clifton‐Bligh, Roderick, Sywak, Mark S.

Get full text